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PTibial Artery Calcification
as a Marker of Amputation Risk
in Patients With Peripheral Arterial Disease
Raul J. Guzman MD,* D. Marshal Brinkley, MD,* Paul M. Schumacher, MD,*
Rafe M. J. Donahue, PHD,† Holly Beavers, RN,* Xiao Qin, MD‡
Nashville, Tennessee; and Guangxi, China
Objectives The purpose of this study was to evaluate the relationship between calcification in tibial arteries, the degree of
limb ischemia, and the near-term risk of amputation.
Background Determining the amputation risk in patients with peripheral arterial disease (PAD) remains difficult. Developing
new measures to identify patients who are at high risk for amputation would allow for targeted interventions
and focused trials aimed at limb preservation.
Methods Two hundred twenty-nine patients underwent evaluation by history, arterial Doppler, and multislice com-
puted tomography of the lower extremities. We then explored the relationship between a tibial artery
calcification (TAC), traditional risk factors for PAD, limb status at presentation, and near-term amputation
risk.
Results Increased age and traditional atherosclerosis risk factors were associated with higher TAC scores. Patients with
critical limb ischemia had the highest TAC scores, and increasing TAC scores were associated with worsening
levels of limb ischemia in ordinal regression analysis. Receiver-operator characteristic analysis suggested that
the TAC score predicted amputation better than the ankle-brachial index (ABI). Symptomatic patients with a TAC
score greater than 400 had a significantly increased risk of amputation. In Cox regression analysis, there was a
strong association between the TAC score and the risk of major amputation that remained after adjustment for
traditional risk factors and the ABI.
Conclusions In patients presenting with PAD, the TAC score is associated with the stage of disease and it identifies those
who are at high risk for amputation better than traditional risk factors and an abnormal ABI. (J Am Coll Cardiol
2008;51:1967–74) © 2008 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.12.058a
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aeripheral arterial disease (PAD) affects approximately 5
illion Americans (1), and it is associated with decreased
uality of life (2,3), increased risk of death (4,5), and
ncreased risk of limb-threatening ischemia (6). The major-
ty of patients with symptoms of early PAD remain stable;
ver time, however, 15% to 25% develop progressive disease
equiring vascular intervention and 1 in 25 will require
mputation (7,8). Despite our skill in identifying lower
xtremity arterial disease using exam and noninvasive test-
ng, our ability to identify the subset of patients with PAD
ho will ultimately require amputation remains limited.
rom the *Division of Vascular Surgery and †Department of Biostatistics, Vanderbilt
niversity Medical Center, Nashville, Tennessee; and ‡Guangxi Medical University
irst Affiliated Hospital, Guangxi, China. This work was funded by grants from the
ational Institutes of Health, DK06736 and HL069926, and a research award from
he Lifeline Foundation and the William J. von Liebig Foundation.c
Manuscript received October 12, 2007; revised manuscript received December 17,
007, accepted December 17, 2007.While extensive investigations on the role of coronary
rtery calcification and its use as a marker of coronary
isease have been made over the last 15 years (9–11), similar
tudies using computed tomographic (CT)-based methods
hat focus on lower extremity calcification have not been
ndertaken. When lower extremity arterial calcification is
See page 1975
isible on conventional X-rays, it is associated with an
ncreased risk of amputation (12–15). However, arterial
alcification is thought to begin insidiously, and it may
rogress over years or decades before becoming apparent
16,17). Recent advances in CT imaging technology and
oftware have made it possible to rapidly distinguish be-
ween minimal, early calcification that is difficult to detect,
nd the late, systemic calcification that is easily seen on
onventional X-rays (18).
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Tibial Artery Calcium and Amputation Risk May 20, 2008:1967–74We, thus, established an al-
gorithm for measuring tibial ar-
tery calcification (TAC) using
multidetector CT scanning.
We evaluated the relationship
between the TAC score and the
severity of symptoms. We then
evaluated the association be-
tween the TAC score and the
near-term amputation risk in
patients presenting with symp-
tomatic PAD. Our results sug-
gest that evaluation of tibial
alcification by multislice CT scan may be a useful
ethod for identifying those patients who are at high risk
or amputation.
ethods
ubjects. Between January 2004 and October 2006, 118
atients with symptomatic lower extremity PAD were
ecruited from the vascular clinics of Vanderbilt University
ospital and the Nashville Veterans’Administration Hos-
ital. In addition, we recruited a control group of 111
ommunity volunteers without symptomatic PAD. In order
o exclude the known effects of renal insufficiency and renal
ailure on arterial calcification, patients with a creatinine
reater than 1.7 were excluded from this study. Also
xcluded were patients with type I diabetes, patients who
id not ambulate, patients who had previously undergone a
ajor amputation, patients with acute limb ischemia, pa-
ients who had previously undergone multiple (greater that
) lower extremity revascularization procedures, and pa-
ients presenting with severe ischemia associated with gan-
rene or tissue loss (Rutherford category 6).
atient assessment and group assignments. Patients were
sked about symptoms of PAD including claudication,
schemic rest pain, and ulcers. A further medical history was
btained that involved assessment of vascular risk factors
ncluding a self-reported history of tobacco use, hyperlipid-
mia, hypertension, and diabetes. Patients then underwent
valuation by pulse exam and noninvasive arterial Doppler
esting. Lower extremity physical exam findings and arterial
oppler findings were then used to assign a limb ischemia
ategory according to the criteria set forth by Rutherford
t al. (19).
iochemical measurements. Patients underwent standard
aboratory evaluation for measurement of total cholesterol,
igh-density lipoprotein, low-density lipoprotein, and
riglycerides.
maging. Patients underwent noncontrast CT scanning of
he lower extremities on a single 16-slice CT scanner
MX8000 IDT, Philips Medical, Cleveland, Ohio) that was
alibrated daily and twice monthly using standardized pro-
ocols. Scans were performed using a 3-mm increment,
Abbreviations
and Acronyms
ABI  ankle-brachial index
CLI  critical limb
ischemia
CT  computed
tomography
PAD  peripheral arterial
disease
TAC  tibial artery
calcificationAs  200, and kV  120 with a field of view of 350 to80 mm yielding typical spatial resolution 0.7  0.7  3.0
m3. The scan duration was approximately 15 s. From the
cquired raw data, the scan was reconstructed in 3-mm
lices. The average number of slices was 135  43 slices.
ample images from patients without (A) and with (B)
ibial artery calcium are demonstrated in Figure 1.
ibial artery calcium scoring. Tibial artery calcium scor-
ng was performed using standardized calcium scoring
oftware (Phillips Medical Systems, Amsterdam, the Neth-
rlands) by investigators who were blinded to the results of
he clinical assessment and Rutherford categories. Auto-
ated image analysis was performed using the software on
Dell dual processor computer. On cross-sectional images
hrough the lower extremities, areas of calcification along
he tibial arteries with a cross-sectional area greater than 1
m2 and with a density of 130 Hounsfield units (HU)
ere identified automatically. Regions of interest along the
istal popliteal, anterior tibial, posterior tibial, and peroneal
rteries were manually selected and labeled. Measurements
ere started at the bottom of the patella and ended at the
idest portion of the tibial and fibular malleoli at the ankle.
his usually included the bottom half of the popliteal artery
nd the entire length of the 3 tibial arteries down to the
nkle. This also allowed us to include all anatomical variants
f tibial artery origins. Calcium scores were determined
ccording to the method described by Agatston et al. (9).
his method was chosen because it is currently in wide-
pread use and because it provides a simple transition from
Figure 1 TAC
Noncontrasted multislice computed tomography showing a patient without (A)
and with (B) significant tibial artery calcification (TAC). Arrows identify calcified
tibial arteries.
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May 20, 2008:1967–74 Tibial Artery Calcium and Amputation Riskoronary calcium scoring. Individual calcium values for each
rtery in each lower extremity were added together to derive
single combined TAC score for each patient. Interob-
erver variability was evaluated by 2 readers in a randomly
elected list of 39 scans. The Spearman correlation coeffi-
ient was 0.98 with a value of p  0.001.
ollow-up. Outcomes were determined from patient in-
erviews during routine clinical follow-up. Patients pre-
enting with critical limb ischemia (CLI) were followed
t least monthly until symptoms resolved, healing was
omplete, or amputation occurred. Additional follow-up
ata were obtained through an institutional review
oard–approved chart review and through a follow-up
ompletion survey performed by phone. Time to
ollow-up or event was calculated from the date of the
T scan. We were unable to obtain follow-up on 2
atients (1 patient with claudication and 1 patient with
LI) who did not return for management after their CT
can (98% follow-up). The control population was con-
acted 1 time for follow-up by phone questionnaire. We
ere unable to contact 4 patients in this group (96%
ollow-up). Follow-up of at least 3 months was available
n 223 patients, and the mean follow-up time was 13.8 
.7 months. Minor amputation was defined as any
mputation limited to the distal forefoot up to the
ransmetatarsal level. Major amputation was defined as
ny amputation above the ankle.
tatistical analysis. Statistical computations were carried
ut using the SPSS version 15.0 (SPSS Inc., Chicago,
llinois) and GraphPad Prism 5 (GraphPad Software Inc.,
an Diego, California). Continuous variables were summa-
ized via mean and SD, and dichotomous variables were
ummarized via counts and percents. The normality of
ontinuous variables was checked using the Kolmogorov-
mirnov test. Due to non-normal distributions, compari-
ons of continuous variables across TAC groups and across
Patient Characteristics According to TAC Score
Table 1 Patient Characteristics According t
TAC  0
(n  83)
T
Age, yrs 57 7
Men, % 41
Caucasian, % 89
Type 2 diabetes, % 46
Hypertension, % 55
Hyperlipidemia, % 57
Smoking history 45
Total cholesterol 187 35
HDL cholesterol 54 17
LDL cholesterol 99 39
Triglycerides 194 115
BMI 30.6 7.3
Statin use, % 51
PAD symptoms, % 22BMI  body mass index; HDL  high-density lipoprotein; LDL  low-density
calcification.imb ischemia categories were performed using the Kruskal-
allis test, and post-hoc comparisons were performed
sing Dunn’s post-test. For comparison of dichotomous
ariables across TAC groups and limb ischemia categories,
e used the chi-square test for trend followed by pairwise
omparisons using the chi-square test. Values for TAC
cores were significantly skewed, and for this reason statis-
ics were performed on log-transformed TAC  1 scores.
ssociations of clinical variables with severity of limb
schemia at presentation were assessed using ordinal logistic
egression and expressed as hazard ratios with 95% confi-
ence intervals. Receiver-operator characteristic curves were
enerated for TAC and ankle-brachial index (ABI) versus
ajor and major plus minor amputation. Event-free curves
or major amputation were generated using Kaplan-Meier
nalysis and compared using the log-rank test. Predictors of
ajor amputation in patients with PAD were evaluated
sing Cox proportional hazards regression. Hazard ratios,
5% confidence intervals, and p values are listed. In order to
aintain the predictive accuracy of different ranges of ankle
ressures for limb ischemia, ABIs were categorized accord-
ng to the following scale: 0 for normal ABIs of 0.9 to 1.4;
for diminished ABIs of 0.6 to 0.9; 2 for ABIs between 0.3
o 0.6; and 3 for ABIs below 0.3 and for noncompressible
essels.
esults
atient characteristics at baseline. A total of 229 patients
ompleted the study and were included in the initial analysis
f risk factors for TAC (Table 1). Interestingly, total
holesterol levels and low-density lipoprotein were inversely
elated to the tibial calcification score; however, there was a
rend toward increased statin use in patients with higher
AC scores. Patients with higher TAC scores had a higher
ncidence of PAD symptoms.
Score
1 to 503
72)
TAC >503
(n  74) p Value
 8 67 10 0.0001
69 76 0.0001
85 74 0.1128
68 74 0.0004
72 78 0.0001
63 72 0.0010
74 81 0.0004
 43 162 42 0.0002
 14 44 14 0.0003
 29 79 29 0.0026
 150 204 137 0.6054
 5.4 28.7 7.5 0.1658
61 65 0.0667
53 85 0.0001o TAC
AC 
(n 
60
178
46
88
213
29.1lipoprotein; PAD  peripheral arterial disease; TAC  tibial artery
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Tibial Artery Calcium and Amputation Risk May 20, 2008:1967–74AC score is associated with severity of limb ischemia at
resentation. The control population was generally well
atched with the claudication group, but patients present-
ng with CLI were older, more likely to be men, and more
ikely to have type 2 diabetes, hypertension, and a history of
obacco use. The TAC score increased significantly between
he control and claudication groups and between the clau-
ication and CLI groups (Fig. 2, Table 2).
We next assessed the association between the TAC score
nd the level of ischemia at presentation. When we divided
atients according to TAC ranges, the proportion of pa-
ients presenting with CLI increased from 0% in the lowest
roup to 57% for patients with a TAC score of greater than
,000 (Fig. 3). In order to adjust for the possible confound-
ng effects of demographic and risk factors, we used ordinal
ogistic regression to evaluate the association between the
AC score and limb status at presentation (control, clau-
ication, or CLI). After correcting for age, male gender,
ype II diabetes, hypertension, hyperlipidemia, and tobacco
Figure 2 TAC Scores by Limb Status
Tibial artery calcification (TAC) scores in patients without (control group) and
with peripheral arterial disease (claudication and critical limb ischemia [CLI]).
Each dot represents a single patient. Open circles represent patients who sub-
sequently underwent major amputation. Lines represent median for each
group.
Patient Characteristics According to Severity of
Table 2 Patient Characteristics According t
Control Group
(n  111)
Claudica
(n  74
Age (yrs) 59 7 60 1
Men (%) 54 65
Caucasian (%) 89 77*
Type 2 DM (%) 59 55
Hypertension (%) 59 72
Hyperlipidemia (%) 53 77‡
Tobacco use (%) 47 81‡
BMI (kg/m2) 30.3 6.7 29.4 6
TAC 0 (0, 12,093) 107 (0, 19,
*p  0.05 versus control group; †p  0.05 versus claudication group;
artery calcification (TAC) scores are expressed as median (minimum, maxim
BMI  body mass index; CLI  critical limb ischemia; DM  diabetes mellse, the TAC score continued to have a strong association
ith worsening ischemia (Table 3).
AC score predicts amputation. During follow-up, a
otal of 28 amputations occurred in our vascular patient
opulation while no amputations occurred in the control
atient population. In the group of 74 patients initially
resenting with claudication, there were 3 amputations (2
inor and 1 major). In the group of 45 patients presenting
ith CLI, there were 25 amputations. Of these, 15 were
ajor and 10 were minor amputations. Receiver-operator
haracteristic curves were generated to evaluate the predic-
ive value of TAC for amputation and to compare it with
he ABI. When we evaluated these measures versus major
mputation, the area under the curve for TAC was greater
han that for the ABI (Fig. 4A). When we evaluated these
easures versus the combined end point of major and minor
mputation, the area under the curve for TAC remained
reater than that for ABI (Fig. 4B). Thus, receiver-operator
Ischemia at Presentation
erity of Limb Ischemia at Presentation
CLI
(n  44) p Value
67 11*† 0.0001
73* 0.0223
77 0.0314
82‡§ 0.0263
86‡ 0.0006
66 0.0267
86‡ 0.0001
27.7 7.7 0.3914
4,475 (24, 23,392)‡§ 0.0001
.01 versus control group; §p  0.01 versus claudication group; Tibial
0
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0-10 1-1000 >1000
TAC
Pa
tie
nt
s
control
claudication
CLI
Figure 3 Clinical Presentation by TAC Range
Patients were divided according to tibial artery calcification (TAC) categories (0
to 10, 10 to 1,000, and 1,000). Bars represent the number of patients with
no disease (red bars, control group), claudication (blue bars), or critical limb
ischemia (CLI) (black bars).Limb
o Sev
tion
)
0
.5
848)‡
‡p  0
um).
itus.
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May 20, 2008:1967–74 Tibial Artery Calcium and Amputation Riskharacteristic curves, while not corrected for possible con-
ounders, indicate that the TAC score is a better marker of
mputation risk than the ABI. We identified a TAC cutoff
alue of 400 which, when applied to our symptomatic
ascular patient population, yielded a sensitivity of 94%, a
pecificity of 46%, a positive predictive value of 23% (15 of
5), and a negative predictive value of 98% (1 of 59) for
ajor amputation.
Kaplan-Meier curve analysis was performed using a cutoff
AC value of 400 for the prediction of major amputation in
ymptomatic vascular patients. The log-rank test showed
hat patients presenting with vascular symptoms and a TAC
core400 had a significantly higher major amputation rate
ompared with patients with a TAC score 400 (Fig. 5).
In our final analysis, we used Cox proportional hazards
nalysis to evaluate predictors of major amputation includ-
ng TAC 400 in our symptomatic vascular patient popu-
ation (Rutherford categories 1 to 5). Interestingly, in
nivariate analysis, traditional risk factors and the ABI lost
heir predictive value while a TAC 400 remained predic-
ive. In multivariate analysis, after adjusting for age and
BI, the hazard ratio for a TAC 400 was 11.27 (p 
.025) (Table 4). These findings suggest that in patients
resenting to the vascular service with symptomatic PAD, a
AC score 400 predicts amputation better than demo-
raphics, risk factors, and the ABI.
iscussion
ur study showed for the first time that multislice CT can
e used to quantify calcification in the tibial arteries and that
AC is strongly associated with the stage of lower extremity
ascular disease and the near-term risk of major amputation.
his association was preserved after correction for tradi-
ional risk factors and the ABI, an indirect measure of pedal
erfusion. Patients without tibial calcification did not re-
uire amputation, while 1 in 5 patients presenting with
schemic symptoms and a TAC score 400 underwent
ajor amputation. Our study suggests that tibial artery
alcium may be a useful measure to stratify patients into risk
djusted HR for Increasingeverity of Limb Is hem a at Presentation*
Table 3 Adjusted HR for IncreasingSeverity of Limb Ischemia at Presentation*
HR (95% CI) p Value
Age 1.003 (0.970–1.037) 0.8611
Men 0.814 (0.426–1.555) 0.5327
Caucasian 1.065 (0.486–2.336) 0.8746
Type 2 diabetes 0.809 (0.430–1.519) 0.5091
Hypertension 1.833 (0.930–3.614) 0.0800
Hyperlipidemia 1.229 (0.662–2.282) 0.5131
Smoking history 3.683 (1.886–7.194) 0.0001
TAC score† 2.548 (1.945–3.340) 0.0001
Control, claudication, and critical limb ischemia groups; †log-transformed tibial artery calcifica-
ion (TAC) values were used for statistics.
CI  confidence interval; HR  hazard ratio; TAC  tibial artery calcification.ategories and to guide therapy aimed at limb preservation.The initial diagnosis of PAD in patients is uncompli-
ated. Once the diagnosis of PAD is made, however,
etermining which patients have a poor limb prognosis with
ltimate need for major amputation remains problematic.
hile an abnormal ABI can predict all-cause and
ardiovascular-specific mortality (20), it correlates poorly
ith symptoms (21), can give misleading results in patients
ith calcified vessels (22), and cannot predict healing after
orefoot amputation (23). Our results suggest that the TAC
core may be most useful in this at-risk patient cohort with
nown vascular disease. Patients with low or normal TAC
cores could be safely managed with conventional medical
anagement, whereas patients with a TAC score above a
ertain threshold might benefit from more intensive medical
herapy, custom shoes, and more frequent foot examination,
nd they may also be more suitable for participation in
linical trials aimed at preventing amputation.
Abdominal, pelvic, and lower extremity calcification have
reviously been shown to reflect advanced occlusive disease
nd increased risk of cardiovascular events (12–15,24–27).
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Figure 4 ROC Analysis
Receiver-operator characteristic (ROC) curves for the predictive value of tibial
artery calcification (TAC) and ankle-brachial index (ABI) on major amputation (A)
and on major and minor amputation (B). The black line represents the ROC
curve for TAC score. The blue line represents ROC curve for ABI. The red line
represents no effect. AUC  area under the curve.
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Tibial Artery Calcium and Amputation Risk May 20, 2008:1967–74ecent studies have focused on patients with chronic kidney
isease (28), and there is a well-known association of
ncreased systemic vascular calcification in patients on dial-
sis (29–33). Relationships between the macroscopic arte-
ial calcification that is visible on conventional X-rays and
lucose tolerance (34), neuropathy (35), mortality rates, and
omplications of diabetes including amputation have also
een demonstrated (12). However, the utility of quantitative
ssessment of vascular calcification by multislice CT has not
een evaluated.
We propose a scoring protocol for lower extremities
ased on the extensive investigations previously performed
n coronary artery calcium (9). Our rationale for assessing
rterial calcification in the tibial vessels was related to
revious work suggesting an association between distal
alcific disease and amputation (12). It was also based on the
nown relationships between diabetes, tibial atherosclerosis,
Figure 5 Major Amputation Events
According to TAC Score for Patients With PAD
Symptomatic vascular patients were stratified by tibial artery calcification (TAC)
scores 400 or 400. Kaplan-Meier curves were derived for major amputa-
tion-free survival. The p value is derived using the log-rank test. Number of
patients at risk at each time point is listed on the bottom. PAD  peripheral
arterial disease.
HRs for Major Amputation in Patients Presentin
Table 4 HRs for Major Amputation in Patien
Univariate Analysis
HR (95% CI)
Age 1.04 (0.996–1.086)
Men 2.27 (0.645–7.965)
Caucasian 0.87 (0.281–2.705)
Type 2 diabetes 1.04 (0.390–2.771)
Hypertension 1.42 (0.406–5.002)
Hyperlipidemia 1.63 (0.466–5.737)
Smoking history 0.82 (0.232–2.865)
ABI 1.73 (0.971–3.084)
TAC 400 14.40 (1.90–109.112)ABI  ankle-brachial index; PAD  peripheral arterial disease; other abbreviand limb loss (36). While there are significant risk factor
ssociations for calcified atherosclerosis in different vascular
eds (37), we suspected that the amount of calcific disease in
he tibial vessels would most strongly reflect the degree of
lood-flow impairment to the foot. We excluded calcifica-
ion in the aortoiliac and femoral regions based on the fact
hat chronic, single-level disease above the knee is infre-
uently associated with CLI (38), while tibial artery disease,
ven in an isolated form, can lead to amputation (39).
dditionally, the risk factors for aortoiliac and femoropop-
iteal disease are known to be different from those for tibial
cclusive disease (40), and we did not want to confound the
ssociations between the TAC score, risk factors, and end
tage events.
In order to remain consistent with the methods used for
coring coronary calcium, we did not attempt to distinguish
etween intimal and medial calcification. Previous studies
ave suggested that medial, but not intimal, calcification
redicts cardiovascular events (12–14). We are unable to
etermine if our results would have been different had we
ocused on medial calcification; however, the predictive
bility of the TAC score remains strong. A comparison of
he total calcification score with a scoring system based
olely on medial calcification may yield insight into the
athophysiological importance of the 2 types of calcifica-
ion. Finally, the progression rate of TAC is unknown. It
as previously thought that PAD patients progressed con-
ecutively through the stages of ischemia from mild to
evere claudication then to rest pain or ulceration. However,
e now know that many patients presenting with CLI
rogressed rapidly, and previous studies suggest that more
han one-half of CLI patients are asymptomatic 6 months
rior (41). Our data show that many patients with high
AC scores had minimal symptoms of lower extremity
ascular disease. Further studies will be needed to determine
f this subgroup of patients with high TAC and minimal or
o symptoms are indeed the same patients who will go on to
evelop CLI.
tudy limitations. Our study has several limitations. First,
e chose to modify the Agatston scoring system for use in
he tibial arteries because of its widespread integration in
h PAD
esenting With PAD
Multivariate Analysis
alue HR (95% CI) p Value
79 1.001 (0.955–1.049) 0.980
02
13
38
81
43
51
63 1.33 (0.732–2.433) 0.346
10 11.27 (1.353–93.842) 0.025g Wit
ts Pr
p V
0.0
0.2
0.8
0.9
0.5
0.4
0.7
0.0
0.0tions as in Table 3.
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May 20, 2008:1967–74 Tibial Artery Calcium and Amputation Riskoronary artery scoring; however, it is possible that other
coring methods such as the volumetric method of Callister
42) or the mass scoring method initially suggested by
etrano et al. (43) would be better for comparing scores at
ifferent centers and for tracking calcium changes over time.
uture work will be needed to address this issue. We have
ot fully addressed the variability in the performance or
nterpretation of scans. However, our interobserver variabil-
ty was excellent with a Spearman correlation coefficient of
.98, and in coronary arteries, the technique is remarkably
obust (44). We chose to use parameters similar to those
sed for coronary artery calcium scoring including a 3-mm
lice thickness and nonoverlapping segments; however,
ptimization of parameters for efficient comparison and
racking of TAC scores will be needed. The scoring method
ill also need to be validated against other calcium assess-
ent systems and against the total amount of occlusive
isease. We did not demonstrate utility of the TAC score in
atients within specific Rutherford groups owing to the
imited number of events; however, when we assessed the
redictive value of TAC for major and minor amputations
n patients presenting with Rutherford categories 1 to 4,
AC was a significant factor (p  0.010), although there
ere only 3 amputations in this group (2 minor and 1
ajor). When we included the presence or absence of CLI
s a variable in logistic regression analysis, the p value for
AC approached significance (p  0.060). Larger and
onger-term studies will be needed to determine the asso-
iative and predictive aspects of TAC scoring in individual
atient subpopulations. There was selection bias in our
opulation in that over one-half of our subjects came from
 referral vascular surgery practice. While we tried to
ompensate for this by recruiting asymptomatic volunteers
rom the community, our results cannot be extrapolated to
he overall population. We did not include toe pressures or
 toe-brachial index in our analysis of predictors for major
mputation, and this may be a better measure of limb
schemia in patients with calcified vessels (22). Additionally,
ur study does not take into account the various efforts at
imb salvage, and, in particular, we have not categorized the
ttempts at revascularization, wound care, or other treat-
ents that were offered to the patients in our study. Tibial
rtery calcification scores, however, were unknown to phy-
icians recommending amputation, and they were not used
or clinical decision-making.
onclusions
e have demonstrated that: 1) tibial artery calcium scores
re higher in patients with PAD than in asymptomatic
ontrol subjects; 2) increasing calcium scores are associated
ith increasing severity of PAD; and 3) the TAC score
redicts the short-term risk of amputation, independent of
ther risk factors and the ABI. Further efforts to evaluate
he pathophysiological mechanisms relating tibial artery
alcium accumulation to CLI are warranted, as are clinical
1nvestigations aimed at preventing lower extremity amputa-
ion in this high-risk population.
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